Obtain a position that will enable use strong sales / marketing background, interpersonal skills and managerial
abilities for achieving the company's marketing goals in the best possible way.
I wish to get associated with a clothes retailing company which would utilize
my abilities for achieving its business targets.
Not exact matches
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our
ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our
ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our
ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our
ability to
achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential
for additional forward losses on new and maturing programs; 5) our
ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences
for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our
ability to obtain in a timely fashion any required regulatory or other third party approvals
for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our
ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our
ability to enter into profitable supply arrangements with additional customers; 12) the
ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand
for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our
ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our
ability to borrow additional funds or refinance debt, including our
ability to obtain the debt to finance the purchase price
for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's
ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our
ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate
for our additional capital needs or
for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our
ability to effectively assess, manage and integrate acquisitions that we pursue, including our
ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our
ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions
for ourselves and Asco as a result of the acquisition; 33) our
ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our
ability to complete the proposed accelerated stock repurchase plan, among other things.
Factors which could cause actual results to differ materially from these forward - looking statements include such factors as the Company's
ability to accomplish its business initiatives, obtain regulatory approval and protect its intellectual property; significant fluctuations in marketing expenses and
ability to
achieve or grow revenue, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management's
ability to attract and maintain qualified personnel necessary
for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission.
Whether you're a brand new startup or a fairly well - established brand, your
ability to
achieve your goals is ultimately going to depend on what you get out of the people who work
for you.
The K9 Resorts Franchise opportunity has the unique
ability to allow potential franchisees the opportunity to
achieve income and lifestyle objectives by connecting their respect and love
for dogs with the application of the K9 Resorts franchise model.
Actual results and the timing of events could differ materially from those anticipated in the forward - looking statements due to these risks and uncertainties as well as other factors, which include, without limitation: the uncertain timing of, and risks relating to, the executive search process; risks related to the potential failure of eptinezumab to demonstrate safety and efficacy in clinical testing; Alder's
ability to conduct clinical trials and studies of eptinezumab sufficient to
achieve a positive completion; the availability of data at the expected times; the clinical, therapeutic and commercial value of eptinezumab; risks and uncertainties related to regulatory application, review and approval processes and Alder's compliance with applicable legal and regulatory requirements; risks and uncertainties relating to the manufacture of eptinezumab; Alder's
ability to obtain and protect intellectual property rights, and operate without infringing on the intellectual property rights of others; the uncertain timing and level of expenses associated with Alder's development and commercialization activities; the sufficiency of Alder's capital and other resources; market competition; changes in economic and business conditions; and other factors discussed under the caption «Risk Factors» in Alder's Annual Report on Form 10 - K
for the fiscal year ended December 31, 2017, which was filed with the Securities and Exchange Commission (SEC) on February 26, 2018, and is available on the SEC's website at www.sec.gov.
Actual results, including with respect to our targets and prospects, could differ materially due to a number of factors, including the risk that we may not obtain sufficient orders to
achieve our targeted revenues; price competition in key markets; the risk that we or our channel partners are not able to develop and expand customer bases and accurately anticipate demand from end customers, which can result in increased inventory and reduced orders as we experience wide fluctuations in supply and demand; the risk that our commercial Lighting Products results will continue to suffer if new issues arise regarding issues related to product quality
for this business; the risk that we may experience production difficulties that preclude us from shipping sufficient quantities to meet customer orders or that result in higher production costs and lower margins; our
ability to lower costs; the risk that our results will suffer if we are unable to balance fluctuations in customer demand and capacity, including bringing on additional capacity on a timely basis to meet customer demand; the risk that longer manufacturing lead times may cause customers to fulfill their orders with a competitor's products instead; the risk that the economic and political uncertainty caused by the proposed tariffs by the United States on Chinese goods, and any corresponding Chinese tariffs in response, may negatively impact demand
for our products; product mix; risks associated with the ramp - up of production of our new products, and our entry into new business channels different from those in which we have historically operated; the risk that customers do not maintain their favorable perception of our brand and products, resulting in lower demand
for our products; the risk that our products fail to perform or fail to meet customer requirements or expectations, resulting in significant additional costs, including costs associated with warranty returns or the potential recall of our products; ongoing uncertainty in global economic conditions, infrastructure development or customer demand that could negatively affect product demand, collectability of receivables and other related matters as consumers and businesses may defer purchases or payments, or default on payments; risks resulting from the concentration of our business among few customers, including the risk that customers may reduce or cancel orders or fail to honor purchase commitments; the risk that we are not able to enter into acceptable contractual arrangements with the significant customers of the acquired Infineon RF Power business or otherwise not fully realize anticipated benefits of the transaction; the risk that retail customers may alter promotional pricing, increase promotion of a competitor's products over our products or reduce their inventory levels, all of which could negatively affect product demand; the risk that our investments may experience periods of significant stock price volatility causing us to recognize fair value losses on our investment; the risk posed by managing an increasingly complex supply chain that has the
ability to supply a sufficient quantity of raw materials, subsystems and finished products with the required specifications and quality; the risk we may be required to record a significant charge to earnings if our goodwill or amortizable assets become impaired; risks relating to confidential information theft or misuse, including through cyber-attacks or cyber intrusion; our
ability to complete development and commercialization of products under development, such as our pipeline of Wolfspeed products, improved LED chips, LED components, and LED lighting products risks related to our multi-year warranty periods
for LED lighting products; risks associated with acquisitions, divestitures, joint ventures or investments generally; the rapid development of new technology and competing products that may impair demand or render our products obsolete; the potential lack of customer acceptance
for our products; risks associated with ongoing litigation; and other factors discussed in our filings with the Securities and Exchange Commission (SEC), including our report on Form 10 - K
for the fiscal year ended June 25, 2017, and subsequent reports filed with the SEC.
A candidate becomes interesting to him,
for example, if he or she has been active in leading a non-profit organization or a sports team where finances are limited and the individual can demonstrate an
ability to
achieve goals by leveraging creative resources and leadership skills.
In particular, as disclosed in filings with the U.S. Securities and Exchange Commission, Amarin's
ability to effectively develop and commercialize Vascepa will depend in part on its
ability to continue to effectively finance its business, efforts of third parties, its
ability to create market demand
for Vascepa through education, marketing and sales activities, to
achieve increased market acceptance of Vascepa, to receive adequate levels of reimbursement from third - party payers, to develop and maintain a consistent source of commercial supply at a competitive price, to comply with legal and regulatory requirements in connection with the sale and promotion of Vascepa and to maintain patent protection
for Vascepa.
These risks and uncertainties include: Gilead's
ability to
achieve its anticipated full year 2018 financial results; Gilead's
ability to sustain growth in revenues
for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement
for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding
for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's
ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's
ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's
ability to submit new drug applications
for new product candidates in the timelines currently anticipated; Gilead's
ability to receive regulatory approvals in a timely manner or at all,
for new and current products, including Biktarvy; Gilead's
ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's
ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's
ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
For me, it all starts with the conditions I've set for achieving my own definition of «satisfaction»: the ability to make money, grow professionally and have fun doing
For me, it all starts with the conditions I've set
for achieving my own definition of «satisfaction»: the ability to make money, grow professionally and have fun doing
for achieving my own definition of «satisfaction»: the
ability to make money, grow professionally and have fun doing it.
While the company believes the forward - looking statements contained in this press release are accurate, there are a number of factors that could cause actual events or results to differ materially from those indicated by such forward - looking statements, including, without limitation, estimates of future performance, and the
ability to successfully develop, receive regulatory clearance, commercialize and
achieve market acceptance
for any products.
For example, the expected timing and likelihood of completion of the proposed merger, including the timing, receipt and terms and conditions of any required governmental and regulatory approvals of the proposed merger that could reduce anticipated benefits or cause the parties to abandon the transaction, the
ability to successfully integrate the businesses, the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement, the possibility that Kraft shareholders may not approve the merger agreement, the risk that the parties may not be able to satisfy the conditions to the proposed transaction in a timely manner or at all, risks related to disruption of management time from ongoing business operations due to the proposed transaction, the risk that any announcements relating to the proposed transaction could have adverse effects on the market price of Kraft's common stock, and the risk that the proposed transaction and its announcement could have an adverse effect on the
ability of Kraft and Heinz to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers and on their operating results and businesses generally, problems may arise in successfully integrating the businesses of the companies, which may result in the combined company not operating as effectively and efficiently as expected, the combined company may be unable to
achieve cost - cutting synergies or it may take longer than expected to
achieve those synergies, and other factors.
Employers are adopting resilience training
for their employees at a rate faster than any other intervention in the United States.1 Resilience — the
ability to use positive mental skills to remain psychologically steady and focused when faced with challenges or adversity — contributes substantially to how workers deal with stress and perform at work.2, 3 Employers are developing resilience to
achieve a competitive advantage, similar to how the military trains active duty soldiers and their family members to withstand challenges.4, 5
Such risks and uncertainties include, but are not limited to: our
ability to
achieve our financial, strategic and operational plans or initiatives; our
ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our
ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our
ability to obtain shareholder or regulatory approvals required
for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the
ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.
services does not decrease over time as we expect, or we are not able to establish VSOE
for professional services revenue, then our
ability to
achieve profitability will be negatively impacted.
The orders are also, in the Lutheran view, a school in which all citizens are educated to care
for each other, to do their duties even against their egoistic drives, and to use their «liberty and
ability to
achieve civil righteousness,» as Article XVIII of the Apology of the Augsburg Confession puts it.
Good communication is the
ability to transmit and receive meanings; it is the instrument
for achieving that mutual
Having developed the capacity
for intimacy, young adults enter the mature years with the
ability to bear responsibility and
achieve their maximum productivity.
True church unity is
achieved when each person recognizes that all other people have different tastes, desires, interests, and
abilities, and rather than see these differences in others as weaknesses to be exploited or flaws to be fixed, this diversity is celebrated and enjoyed as part of God's plan and purpose
for the church.
For Merleau - Ponty, the self's spontaneous interpretative
abilities are not capricious or arbitrary; rather, they are teleologically governed by the goal of
achieving a certain equilibrium with the world.
But finally the ministers who, as Lyman Beecher said, were «chosen by the people who have been educated as free men,» and were «dependent on them
for patronage and support, «88
achieved such status as their reputation
for personal piety, character, and
ability made possible in the society in which they lived.
IGNITOR's
ability to provide a more efficient release of BCAAs and glutamine allows
for formulations that contain less protein to
achieve desired effectiveness levels.
And, most importantly — the
ability to
achieve your case packing goals, with a packer designed
for your needs, to your specifications and within your budget.
VERYX sorters offer in - air inspection and the
ability to view all sides of the product,
achieving complete surface inspection with no blind spots
for superior detection and removal of green beans with surface blemishes.
Nathan believes there is massive potential
for the organic industry to develop, but the more demanding crops and the
ability to
achieve higher yields is holding the industry back.
Beyond this, the unique power of GM lies in its
ability to incorporate novel genes with useful traits
for rice, including genes from plants and organisms unrelated to rice, into new rice varieties that can not be
achieved using other breeding methods.
Rainforest Alliance recently announced the release of an important study outlining an overlooked benefit
for farmers of
achieving certification: the
ability to get larger and more frequent small loans.
The professional success of a college's former players certainly provides an indirect boost to the college's
ability to
achieve its primary goal (a la national exposure and examples
for future recruits to look to); however, getting one's former players drafted or ensuring their future success is NOT the primary goal.
look the problem i see is, campbell is a solid player but i doubt he has potential upwards i think he has already
achieved his
ability which he will maintain through the years and thats solid, he would be a good back - up, but he does nt want that, so no choice there whereas ox is back - up and theo is the only one right now who on form has enough output / production in that slot
for a starter - role
The same is applied to players... if they are under performing or lack certain
abilities required
for the job, they are preventing the team from
achieving their goals — and that is to win.
Even though Wenger has lost his
ability to motivate and inject a winning mentality into his Players, Every Arsenal fan needs to show him some respect
for what he
achieved in his early years at the club, not only
for Arsenal fc but
for the whole of the English game.
Barring biased arsenal or
for that matter biased I'd say English fans (national team) everyone else can see that the biggest difference btwn the pair is this, v.p regardless of how many goals he scored prior to 2009 had something Walcott never had or never will have that is Natural
ability that eventually after his injuries propelled him to the world class level that everyone knew that he was going to
achieve only his injuries were holding him back.
i'm often faced with the question «what have you
achieved with your so called branded beautiful football» and in my quiet time, i think about it and i came up with a conclusion that all teams vie
for one main reason,» to win trophies» which we have lacked in the last six years.As an Economist, i understand Arsene wenger's mentality, philosophy, youth developmental project, rebuilding and most especially, the sole aim of puting Arsenal's financial stability in order but he should also understand that the only consolation we fans get after paying to watch Arsenal despite the high ticket prices which's about the costliest in the league is winning trophies, the
ability to say amongst other footballing fans that we have a great squad that plays good football and win trophies.That's what i'm talking about!!!
That should be
achieved for this season, meaning the club's
ability to spend in the transfer market will be notably stronger (more on that later).
First to be very clear my friend, I am as true gooner as you are but in trying to make your point about the way wenger and the club had managed to
achieve success without the backing of your so called «Angel investor», you had completely missed by point of complementing the emirates with the stars who not only have great footballing skills and also have the
ability to drag crowds into the stadium (and that
for me is the «top» footballing talent).
The conference will pay particular attention to the ways in which issues of race, class, nationality, sexuality, age,
ability, religion and ethnicity affect (positively or negatively) the
ability of mothers to advocate
for and
achieve authority, agency, respect and empowerment.
I don't know who started this myth about the
ability for working moms to
achieve a work / life balance, but I'm thinking I might strangle them if I ever figure it out.
When teachers and schools are able to convey both of those messages at the same time, that you belong here and this is a place where you are welcome, but also that I have high expectations
for your
ability to
achieve things, and I'm going to give you the right kind of help and support
for you to breach those high expectations, those two toolboxes combine to be what is most motivating and inspiring to kids.
Whereas the snoogle only offered the
ability to
achieve more comfortable side sleeping positions, the Cozy Bump pregnancy pillow allows
for stomach sleeping - a previously impossible position.
In Jamaica, Marley had been a folk hero, and while he had
achieved incredible fame, Dick Hebidge argues that many Jamaicans were proud of him
for his
ability to get white audiences to pay attention to his songs of Black retribution (4).
• Key quotes from the NAO report: o «The source of many problems has been the absence of a detailed view of how Universal Credit is meant to work» [page 33] o «The Department is unable to explain to us why it originally decided to aim
for national roll - out from October 2013» [Para 3.7] o «In early 2013, it (DWP) did not have a convincing strategic plan in place» [3.35] o «It is unlikely that UC will be as simple or cheap to administer as originally intended» [15, summary] o «the Department has not
achieved value
for money... wider concerns about the Department's
ability to deal with weak programme management, over-optimistic timescales and a lack of openness about progress.»
Neither House should impede the
ability of the Government to
achieve the best possible results
for the UK in the Brexit negotiations.
Senator Tedisco has shown a tremendous
ability to work across party lines in a bi-partisan, non-partisan fashion to
achieve positive results
for New Yorkers.
It is endorsed by all the governments» statutory nature conservation agencies
for its
ability to
achieve conservation targets
for society at large.
In particular,
achieving parliamentary approval
for supply — i.e. the
ability to spend money — is a make or break issue
for a government, akin to vote of confidence.
«The increasing frequency and intensity of these harmful algae blooms will impact our
ability to
achieve the ultimate goal of restoring a healthy ecosystem in the Bay and put a premium on effective methods to reduce nutrient pollution,» said Don Boesch, President of the University of Maryland Center
for Environmental Science.
The
ability to keep human embryos developing in the lab
for almost 2 weeks —
achieved for the first time this year — should provide new insights into very early human development, and generate debate on whether ethical limits on studying embryos in culture should be extended.
The captive bird's
ability to make the right tool
for the job from unfamiliar materials and using quite different manufacturing methods suggests some understanding of the properties of the material and what might be
achieved with a hook.